title: Diabetes, statins and FH.
authors.affiliation: IMIBIC, Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Córdoba, Spain. Electronic address: fjfuentesjimenez@gmail.com.
authors.forename: F
authors.initials: F
authors.lastname: Fuentes
authors.affiliation: IMIBIC, Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Córdoba, Spain.
authors.forename: J F
authors.initials: JF
authors.lastname: Alcalá-Díaz
authors.affiliation: Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, School of Medicine and Pharmacology, University of Western Australia, Australia.
authors.forename: G F
authors.initials: GF
authors.lastname: Watts
authors.affiliation: Fundación Hipercolesterolemia Familiar, Madrid, Spain.
authors.forename: P
authors.initials: P
authors.lastname: Mata
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000453:epidemiology*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy* / Q000453:epidemiology*; D008297:Male
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors